ARMK three-lens brief
Evidence-based stock research on ARMK. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $68.53 — 27% above current (16 analysts). · Earnings in 4 days (2026-11-16).
- Analyst mean target $68.53 — 27% above current (16 analysts).
- Earnings in 4 days (2026-11-16).
ARMK closed at $53.79 (-0.79%) as of 2026-11-12. Market cap: $14.18B. P/E (trailing) 37.6. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $68.53 — 27% above current (16 analysts).. Concerns: earnings in 4 days (2026-11-16).. Last quarter: Revenue $5.06B, net income $97.66M, free cash flow $374.14M. Watching for: 2026-11-16 earnings release (4 days out).
Why three lenses on ARMK, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARMK across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ARMK" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARMK brief"></iframe>